HIV Prevention Must Remain Priority To Avoid ‘Rebound Effects’ From Introduction Of Potential Vaccine

Project Syndicate: Vaccinating Against an HIV Rebound
Christine Stegling, executive director of the International HIV/AIDS Alliance

“…[Even if a successful vaccine is developed], many complex social, economic, and cultural issues will continue to complicate the war on HIV. We must think carefully about how to introduce a vaccine without unintentionally encouraging ‘rebound effects,’ like the re-emergence of practices that expose people to HIV infection. While an HIV vaccine would no doubt be a game changer, it would be only one of a diverse range of tools needed to contain one of mankind’s deadliest pandemics. For a vaccine to have the greatest impact, we must continue to promote other forms of prevention — such as condom use, medical male circumcision, and use of pre-exposure prophylactics for at-risk populations. … With scientists optimistic that a vaccine is forthcoming, there is no better time to ensure that traditional transmission interventions remain a priority for policymakers, politicians, and donors…” (7/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.